Heart Disease
Fibromyalgia
High Cholesterol Danger?
Toxic Metals
Free Radicals -- Primer
IV Chelation Therapy

Wrong Diet Causes Diabetes

Vibrant Life Home Web
Family Of Three Oral Chelation Formulas
The Wednesday Letter
The Hubbard Human Detoxification Program
Hopeless Diseases -- Invented to Sell Drugs
Wrong Relationship Cause of Disease

Brain Chemical Imbalance
Dr. Garry F. Gordon
Ultimate Resource On Chelation Therapy Home Page

Shopping Cart

Separate Search Page
or search below


Prevent Cancer

Oral Chelation Therapy
Other

Karl Loren's Policy On Psychiatric Drugs
Destruction Of American Education
Write To Karl Loren Table Of Contents

The Matrix of Connective Tissue and Collagenase

Write To Karl Loren About This Page

Source

Collagenases

Connective Tissue and Collagenase

The structure of connective tissue has long been a subject of intensive research in biochemistry. This work is of particular importance, as an efficient treatment of numerous diseases of these tissues strongly depends on our knowledge of their molecular structure.
     Soft connective tissue has generally been shown to consist of collagen fibrils embedded in a gel-like matrix. The collagen fibrils are complex structures which are assembled from tropocollagen sub-units, and which function primarily as supporting elements. These fibrils are surrounded by an extrafibrillar matrix, the macromolecular components of which are mainly proteoglycans.
    Proteoglycans consist of central protein cores with covalently linked heteroglycan chains radiating from them. Most connective tissues contain both large and small proteoglycans. One group of large proteoglycans interacts specifically with hyaluronic acid to form aggregates. In the presence of water, these aggregates form a matrix which connects and maintains the network of collagen fibrils. Small proteoglycans do not form aggregates and are regularly arrayed at the surface of the collagen fibrils in soft connective tissue. Furthermore, type I collagen fibrils have been shown to have specific binding sites for these proteoglycans.
    The complex composition of connective tissue outlined above should be taken into account when tissues need to be disaggregated in research or clinical situations, such as the preparation of suspensions of viable cells for metabolic studies, the isolation of pancreatic islets in diabetes research and the clinical treatment of necrotic tissue. Tissue disaggregation is best achieved by means of the tissue-disintegrating collagenases, assisted by other proteolytic enzymes.

Structure and mode of action  

Although bacterial collagenases have been the subject of investigation for more than 30 years, it is only in the last five years that the structure and mode of action of this family of enzymes have been elucidated (1-4).

Collagenase from Cl. histolyticum
Cl. histolyticum is known to produce a mixture of collagenases which are able to digest the triple helical collagen molecule in situ. The individual collagenases can be divided into two groups.

Cleavage specificity
Group I enzymes obviously cleave type I collagen near the C-terminus with subsequent proteolysis in the area of the N-terminus. Group II enzymes have a cleavage specificity similar to that of mammalian collagenases. They are able to cleave type I collagen across all three chains within the macromolecule.
    The collagen molecule is a triple helix which contains the repetitive sequence -Pro(Hyp)-XGly-Pro(Hyp)-, where X is a neutral amino acid. Collagenase is specific for the X-Gly bond in this sequence, and is thus also able to cleave denatured collagen and other polypeptides with a related primary structure.
    SERVA collagenases also contain a number of other enzymatic activities, including clostripain, which cleaves peptides preferentially at the carboxyl side of arginine residues, a tryptic activity, which acts preferentially at the carboxyl side of arginine and Iysine residues, and neutral non-specific proteases. The particular suitability of SERVA collagenase preparations for degrading intercellular material is partly due to the presence of balanced amounts of these enzymes.

Properties

Mr:

68 - 125,000 (4)

Optimum pH:

7.5 - 8.0

Isoelectric point:

5-35 - 6.20 (4)

Optimum temperature:

37°C

Cofactors
Collagenase requires calcium ions both for full catalytic activity and binding to the collagen molecule.

Inhibitors
Inhibitors of collagenase include cysteine, EDTA, o-phenanthroline, 8-hydroxyquinoline-5-sulfonate, bipyridyl and 2,3-dimercaptopropanol. It is also inhibited by tris buffer above pH 7.5 (5). Collagenase is not inhibited by diisopropylphosphorofluoridate.

Stability and Storage
Collagenase is soluble in water and dilute salt solutions. It is reversibly inactivated at high pH values, and irreversibly inactivated at low pH values. This product should be stored at 4° C to maintain its high activity. Under these conditions, collagenase remains stable without loss of activity for at least two years.

Enzymatic Activities
The collagenolytic activity of SERVA preparations is assayed in our quality control department by two different methods:

"Wünsch" units: Collagenase cleaves the substrate PZ-L-prolyl-L-leucyl-glycyl-L-prolyl-D-arginine producing a yellow fragment PZ-Lprolyl-L-leucine which is determined spectrophotometrically after extraction into ethyl acetate (6),
"FALGPA" units: SERVA also measures collagenolytic activity using 2-furanacryloyl-L-leucylglycyl-
L-prolyl-L-alanine (FALGPA), a collagenase-specific substrate which is hydrolysed more rapidly than any other synthetic substrate, but is resistant to other proteinases produced by Cl. histolyticum (5).
"Mandl" unit: The often used "Mandl" unit (for definition see below) is partly dependent on the concentration of other proteinases present in the preparation. There is therefore no reliable conversion factor between this and other units.
tr>

As the extraneous activities of these preparations are known to contribute to their performance, three further activities are assayed.
Clostripain (7) and trypsin like (8) activities are both measured by their ability to hydrolyse N-benzolyl-L-arginine ethyl ester (BAEE), but clostripain activity is determined in the presence of an activator, DTT (dithiothreitol).
Neutral proteinases are determined by their ability to hydrolyse dimethylcasein, liberated amino acids being determined with 2,4,6-trinitrobenzene sulfonic acid (TNBS) (9).
Full details of all of the above assay procedures are available on request.

 Collagenases: Unit Definitions

Collagenase activity:
Wünsch units: 1 U catalyzes the hydrolysis of 1 µmol 4-phenylazobenzyloxycarbonyl-L-prolyl-L-leucyl-glycyl-L-prolyl-
D-arginine
per minute at 25° C, pH 7.1.

Other units:
FALGPA units: 1 nkatal is the amount of enzymic activity which catalyzes the hydrolysis of 1 nmol of 2-furanacryloyl-L-leucyl-glycylL-prolyl-L-alanine (FALGPA) per second at 25° C, pH 7.5.
Mandl units: 1 U liberates 1 µmol amino acid from collagen expressed as leucine per 5 hours at 37° C, pH 7.5.

Extraneous activities:
Trypsin-like proteases: 1 U catalyzes the hydrolysis of 1 µmol BAEE per minute at 25 ° C, pH 7.6.
Clostripain: 1 U catalyzes the hydrolysis of 1 µmol BAEE per minute at 25° C, pH 7.6, after activation with 1 mM calcium acetate and 2.5 mM dithiothreitol.
Other proteinases: 1 DMC-U catalyzes the cleavage of 1 µmol peptide bond from dimethyl casein per minute at 25° C, pH 7.0, expressed in terms of newly formed terminal amino groups (determined with TNBS).

Collagenases: Applications

Cell Culture
SERVA collagenase is particularly suitable for the isolation of viable cells from tissue. Collagenase is especially valuable when tissues are too fibrous or too sensitive to allow the use of trypsin, which is ineffective on fibrous material, and damaging to sensitive material. Disintegration is usually achieved either by perfusing whole organs, or by incubating smaller pieces of tissue with enzyme solution.
     Short perfusion or incubation times are essential because of the high activity of these preparations, otherwise formation of cell debris and cell aggregates may lead to low cell viability.

The isolation of islets from pancreatic tissue
In recent years, collagenase has been used successfully for the isolation of viable pancreatic islets from several different species (10,11,12).
     Until now, a number of factors have limited the usefulness of this method in the transplantation of human islets. These include marked variations in the activity of collagenase preparations, the presence of b -cell toxic factors, the absence of any correlation between enzyme activity and islet yield and the influence of collagenase on the immunogenicity and chemotactic behaviour of the islets.

Isolation of cardiomyocytes
Collagenase has also been used in the isolation of cardiomyocytes suitable for the preparation of cultures. If tissue disaggregation is accomplished by perfusion of the intact organ with enzyme solution, then collagenase is always the enzyme of choice either alone, or in conjunction with other enzymes such as hyaluronidase (13), or trypsin. Collagenase can also be used when disaggregation is achieved by incubating small pieces of tissue in enzyme solution (14) .

Isolation of hepatocytes
Isolated hepatocytes are used in tumour promotion and initiation studies, for studying cellular control mechanisms and in drug and carcinogen assay systems.
     SERVA "Collagenase Hep Plus" has been independently tested for use in hepatocyte isolation. Hepatocytes were isolated from rat liver by perfusion with a solution of SERVA "Collagenase Hep Plus" (Cat. no. 17447) for 12 - 13 minutes. The viability of the isolated cells was determined using both trypan blue and fluorescein diacetate, and was in all cases found to be in excess of 90 %. Plating efficiency was shown to be greater than 85 % after 2 hours.

Other tissues
Collagenase has also been successfully used for the isolation of cells from bone (15), thyroid glands (16), and ovarian and uterine tissues (17)

References

(1) Bond, M.D. & Van Wart, H.E. (t 984) Biochemistry 23, 3077-85. Purification and separation of individual collagenases of clostridium
histolyticum using red dye ligand chromatography.

(2) Bond, M.D. & Van Wart, H.E. (1984) Biochemistry 23, 3092-99. Relationship between the individual collagenases of Clostridium histolyticum: evidence for evolution by gene duplication.

(3) French, M.K. et al. (1987) Biochemistry 26,681 -7. Limited proteolysis of type I collagen at hyperreactive sites by class I and 11 Clostridium histolyticum collagenases: Complementary digestion patterns

(4) Bond, M.D. & Van Wart, H.E. ( t 984) Biochemistry 23, 3085-91. Characterization of the individual collagenases from clostridium histolyticum.

(5) Van Wart, H.E. & Steinbrink, D.R. (1981) Anal. Biochem. 113, 356-65. A continuous spectrophotometric assay for clostridium histolyticum collagenase.

(6) Wünsch, E. & Heinrich, H.G. (1963) Hoppe-Seyler's Z. Physic Chem.333,149-51. Determination of collagenase.

(7) Kézdy, F.J. et al. (1965) Biochemistry 4,2302-8. Titration of a/ centres in thrombin solutions. Standardization of the enzyme.

(8) Bergmeyer, H.U. (1983) Methods of enzymatic analysis Vol ll 3rd ed.,319-20. Trypsin.

(9) Lin, Y.-C. et al. (1969) J. Biol. Chem.244,789-93. Action of proteolic teolytic enzymes on N,N-dimethyl proteins. Basis for a microassay for proteolytic enzymes.

  (10) Gray, D.W.R. et al. (1984) Diabetes 33,1055-61. A method for isolation of islets of Langerhans from the human pancreas.

(11) Noel, J. et al. (1982) Metabolism 31 (2),184-87. A method for large-scale, high-yield isolation of canine pancreatic islets of Langerhans.

(12) Izumi, R. et al. (1985) Transplantation Proceedings 17 (1), 383-84. Isolation of human pancreatic islets from cryopreserved pancreas.

(13) Nag, A.C. & Cheng, M. (1981) Tissue & Cell 13 (3),515-23. Adult mammalian cardiac muscle cells in culture.

(14) Lindl, T. & Bauer, J. (t 987) Zell- und Gewebekultur: Einführung in die Grundlagen sowie ausgewählte Methoden und Anwendungen
86-7 Fischer, Stuttgart .

(15) Brand, J.S. & Hefley, T.J. (1984) Collagenase and the isolation of cells from bone, in: Cell separation methods and selected a applications, Vol.3, (t 2) 265-83, Acad. Press.

(16) Kerkhof, P.R. (1982) Journal of tissue culture methods 7 (1), 23-6. Preparation of primary cultures of ovine thyroid gland cells.

(17) Marcus, G.J. et al. (1984) Endocrine Research 10 (2),151 -62. Enzymatic dissociation of ovarian and uterine tissues.


 

Collagenase Hep Plus from Cl. histolyticum ca. 0.5-0.9 U/mg lyophil.

+2 °C to +8 °C
R: 36/37/38-42 S: 22-24-26-36/37
EINECS No. 232-582-9  WGK 1
HS-No. 350790000900
Mr ca. 68 000-125 000 [9001-12-1]

(Clostridiopeptidase A; Collagenase A; Collagenase 1; EC 3.4.24.3). Particularly suitable for the isolation of hepatocytes. Viability of hepatic cells:
more than 90 % (determined with trypan blue and fluorescein diacetate). Plating efficiency: more than 85 % (after 2 h).

Unit definition: 1 U according to Wünsch (1) catalyzes the hydrolysis of1 µmol 4-phenylazobenzyloxycarbonyl-L-prolyl-L-leucylglycyl-L-prolyl-D-arginine per minute at 25 °, pH 7.1.

Activity in other units: 0.3 - 0.7 U/mg (1 U catalyzes the hydrolysis of 1 µmol 2-furanacryloyl- L-leucylglycyl-L prolyl-L-alanine (FALGPA) perminute at 25 °, pH 7.5 (1).

Extraneous activities: clostripain, trypsin-like and neutral proteinases determined for each log.

Reference:
1. Van Wart, H.E. & Steinbrink, D.R. (1981) Anal. Biochem. 113,356-65

17447.50  inquire


Collagenase Pan Plus

+2 °C to +8 °C
R: 36/37/38-42 S: 22-24-26-36/37
EINECS No. 232-582-9 WGK 1
HS-No. 350790000900

Activity profile: see Collagenase cat. no. 17449

17451.50  inquire


Collagenase from Cl. histolyticum ca. 0.5-0.9 U/mg lyophil.

+2 °C to +8 °C
R: 36/37/38-42 S: 22-24-26-36/37
EINECS No. 232-582-9 WGK 1
HS-No. 350790909000
Mr ca. 68 000-125 000 [9001-12-1]

(Clostridiopeptidase A; Collagenase A; Collagenase 1; EC 3.4.24.3). Fortissue culture and cell research.

Unit definition: 1 U according to Wünsch (1) catalyzes the hydrolysis of1 µmol 4-phenylazobenzyloxycarbonyl-L-prolyl-L-leucylglycyl-L-prolyl-D-arginine per minute at 25 °, pH 7.1.

Activity in other units: ca. 0.3-0.7 U/mg.

Extraneous activities: Clostripain, trypsin-likeproteinases and neutral proteinase determined for each lot.

References:
1. Wünsch, E. & Heinrich, H.G. (1963) Hoppe-Seyler´s Z. Physiol.Chem. 333, 149-51
2. Bond, M.D. & Van Wart, H.E. (1984) Biochem. 23, 3085-91

17449.01 50 mg

17449.02 250 mg

17449.03 1 g

17449.04 2.5 g



back

 


Special Pages On The Various of 19 Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee High Cholesterol Risk?
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Immune Egg Central Page For All 19 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:24 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.